Apontis Pharma AG (APPH) — Working Capital to Net Assets Ratio
Apontis Pharma AG (APPH) has a Working Capital to Net Assets ratio of 56.7% as of June 2025. Working capital of €17.93 Million (current assets of €21.01 Million minus current liabilities of €3.08 Million) is measured against net assets of €31.62 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Apontis Pharma AG defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apontis Pharma AG Working Capital to Net Assets (2018–2024)
This chart shows how Apontis Pharma AG's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 56.7%, reflecting working capital of €17.93 Million against net assets of €31.62 Million EUR. For the complete balance sheet picture, see APPH asset base.
Annual Working Capital to Net Assets for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Apontis Pharma AG asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.2% | €18.69 Million | €31.02 Million | €23.44 Million | €4.75 Million | ▼ -20.8 pp |
| 2023 | 81.0% | €24.52 Million | €30.26 Million | €35.63 Million | €11.11 Million | ▼ -7.8 pp |
| 2022 | 88.8% | €36.90 Million | €41.57 Million | €42.86 Million | €5.96 Million | ▲ +1.8 pp |
| 2021 | 86.9% | €35.39 Million | €40.71 Million | €38.46 Million | €3.07 Million | ▲ +226.7 pp |
| 2020 | -139.8% | €-4.84 Million | €3.46 Million | €13.49 Million | €18.32 Million | ▼ -75.7 pp |
| 2019 | -64.1% | €-2.98 Million | €4.64 Million | €13.86 Million | €16.83 Million | ▼ -79.6 pp |
| 2018 | 15.4% | €1.08 Million | €7.03 Million | €19.06 Million | €17.98 Million | — |